Croda International PLC closed 35.52% short of its 52-week high of £51.24, which the company achieved on March 22nd.

In a report released today, Charles Bentley, CFA from Jefferies maintained a Buy rating on Croda International (CRDA – Research Report), with a ...

Croda International PLC closed 36.65% below its 52-week high of £51.24, which the company reached on March 22nd.

In a report released today, Charles Eden from UBS maintained a Buy rating on Croda International (CRDA – Research Report), with a price target ...

The projected fair value for Croda International is UK£24.72 based on 2 Stage Free Cash Flow to Equity Current share price of UK£32.20 suggests Croda International is potentially 30% overvalued ...

Overview: Croda International Plc operates in the consumer care, life sciences, and industrial specialty sectors across Europe, the Middle East, Africa, North America, Asia, and Latin America with ...

Croda International reported a slight decline in sales for 2024, with revenue falling one per cent at constant currency to £1.63bn. Excluding Covid-19-related lipid sales from 2023, underlying ...

Overview: Croda International Plc operates in the consumer care, life sciences, and industrial specialty sectors across Europe, the Middle East, Africa, North America, Asia, and Latin America with a ...

So it’s been another transitional year for Croda following two exceptionally strong years in ‘21 and ‘22. Sales growth was weaker than we’d hoped, but proactive actions to cost and drive ...